Navigating the ASX: Oil Surges, Small Caps Shine, and Resource Experts Weigh In
The Australian Securities Exchange (ASX) experienced a turbulent week, marked by significant swings in market sentiment, a dramatic surge in oil prices, and notable gains in the small-cap sector. While the broader market faced headwinds, particularly from fluctuating commodity prices, several junior companies in the resources and biotechnology spaces demonstrated impressive resilience and growth. This report delves into the week’s market movements, highlights key performers, and presents expert insights from a leading resource analyst.
The trading week, concluding on Friday, March 20, saw the S&P/ASX 200 index (XJO) shed 1.72%, while the S&P/ASX Small Ordinaries index (XSO) experienced a sharper decline of 2.85%. Early in the week, the market showed signs of life, staging a recovery on Tuesday after a sluggish start. By Wednesday, a broad-based momentum had propelled the ASX into positive territory. However, this upward trajectory was abruptly halted on Thursday as soaring oil prices sent shockwaves through the market, leaving many investors on edge as the week drew to a close.
Expert Picks: Resource Sector Insights
Gavin Wendt, founding director and senior resource analyst at MineLife, shared his top recommendations, focusing on companies with strong potential in the oil and gas, Western Australian gold, and battery-grade manganese sectors.
ADX Energy (ASX:ADX)
ADX Energy is actively engaged in small-scale oil production in Austria, with ambitious plans to expand its natural gas resource base. The company has recently achieved positive drilling outcomes and has scheduled an additional three wells for the coming months. Furthermore, ADX is exploring a significant, early-stage gas exploration opportunity in Italy, located within a region known for its hydrocarbon potential.Auric Mining (ASX:AWJ)
Auric Mining has established itself as a successful small-scale gold producer. Its initial asset, the Jeffreys Find gold mine near Norseman, has yielded approximately 30,000 ounces of gold and generated around $16 million in net cash, significantly exceeding its acquisition cost of roughly $1.2 million. The company is now developing its second production asset, the Munda gold project, situated near Widgiemooltha. Through a starter pit development and toll treatment of ore, the Munda project has already produced 8,475 ounces, surpassing its initial budget of 6,100 ounces.Firebird Metals (ASX:FRB)
Firebird Metals aims to leverage its proprietary technology to become a near-term producer of battery-grade MnSO4. This compound is a critical cathode material for LMFP batteries, a next-generation enhancement of Lithium Iron Phosphate (LFP) batteries widely used in electric vehicles (EVs). By incorporating manganese into the cathode, LMFP batteries can achieve a 15-20% increase in energy density. Firebird Metals is currently solidifying its intellectual property and is targeting the execution of a world-first Australian demonstration plant by 2026.
Small Caps Making Waves
Amidst the broader market’s fluctuations, several small-cap companies captured investor attention with significant price movements and compelling developments.
Corella Resources (ASX:CR9)
This silica-focused company experienced a notable surge of +36% this week, despite no market-sensitive announcements since a capital raising in December. Corella’s exploration efforts at its Bonnie Rock and Earoo projects have clearly resonated with the market. With a market capitalisation of approximately $20 million, CR9 operates in a more speculative segment, focusing on silica and kaolin clay deposits that can be processed into high-purity quartz, high-purity alumina, and high-purity kaolin. The company has outlined plans for further exploration at both projects over the next twelve months, employing techniques such as quartz vein and soil sampling to identify potential drill targets.Patagonia Lithium (ASX:PL3)
The Argentine explorer saw a remarkable gain of +44%, continuing its impressive recovery from the lows of the lithium downturn. Having previously traded as low as 3 cents in June, the company’s market value has since increased sixfold to 18 cents. This resurgence coincides with a significant rebound in lithium chemical prices, which have roughly doubled to approximately US$22,000 per tonne, while spodumene prices have more than tripled to US$2,100 per tonne, driven by robust demand from the burgeoning battery sector. Patagonia Lithium’s Formentera brine project in Argentina is attracting renewed interest. The company is pursuing a direct lithium extraction (DLE) approach to commercialise its resource in Jujuy Province. An updated JORC resource estimate last year boosted its lithium carbonate equivalent (LCE) tonnes by an impressive 319% to 551,400 tonnes.
- Racura Oncology (ASX:RAC)
Racura Oncology has been on a significant upward trajectory, with its share price climbing by approximately $1.40, or 133%, since August of the previous year. The company has made substantial progress in navigating regulatory pathways for two key studies evaluating its lead drug, RC220. Racura has successfully dosed the third and final patient in the first cohort of a Phase I trial investigating the cardioprotective and anti-cancer synergistic effects of RC220 when combined with the chemotherapy drug doxorubicin. Additionally, a HARNESS-1 Phase I study is set to assess RC220 in conjunction with the targeted tumour drug osimertinib, with site initiation scheduled for March 23. Racura is targeting solid tumours and non-small cell lung cancer, which represents a significant portion of cancer diagnoses. While Racura is demonstrating promising progress in establishing the safety profile of RC220, it is important to note that biotechnology stocks inherently carry speculative risk, with trial outcomes capable of significantly impacting share prices.
